BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging & Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251204T080000
DTEND;TZID=Europe/Vienna:20251205T170000
DTSTAMP:20260419T094243
CREATED:20241017T084515Z
LAST-MODIFIED:20250624T123657Z
UID:1968-1764835200-1764954000@esmit.eanm.org
SUMMARY:Nuclear Medicine in Breast Cancer Based on FOCUS Meeting 6
DESCRIPTION:Breast cancer is the most relevant cancer in women worldwide. It is the second most frequently diagnosed cancer (after lung cancer) and the first leading cause of cancer-related death in women\, being the fourth globally regardless of gender. By 2040\, breast cancer is predicted to increase to over 3 million new cases and 1 million deaths per year. \n\n\n\nStaging patients with breast cancer is challenging due to its heterogeneous nature and presentation. Imaging is of utmost importance in all clinical settings\, particularly\, in staging\, assessing therapy response\, and detecting recurrence. Despite the well-stablished usefulness of radiologic modalities\, Nuclear Medicine has demonstrated an important role to play in breast cancer\, which has been increasingly supported by strong scientific evidence. Considering the patient’s long survival\, the benefits of assessing active tumour in an accurate way\, gain major importance in these patient’s care. \n\n\n\nThe recent equipment and radiopharmaceutical developments have opened the path to improve tumour characterization through several imaging possibilities. Currently\, the challenge is to use the correct combination of equipment and tracer at the right time. Furthermore\, homogenize imaging and clinical procedures is becoming even more important. \n\n\n\nDuring this course\, the highlights from the consensus reached during the multidisciplinary EANM Focus Meeting 6 about Nuclear Medicine diagnostics and therapeutics possibilities will be comprehensively presented and discussed in a close way between the faculty and attendees. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo understand breast cancer as a heterogeneous disease\, its characteristics and evolution;\n\n\n\nTo define the role of nuclear medicine techniques in different clinical settings (initial staging\, assessing therapy response\, and detecting recurrence);\n\n\n\nTo know the potential usefulness of PET tracers beyond FDG in each breast cancer subtype and use of the evolving PET technology & equipment;\n\n\n\nTo discuss future diagnostic and treatment approaches with radiopharmaceuticals.\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear Medicine physicians\, Radiologists\, Medical Oncologists\, Radiation Oncologists\, Medical students\, Residents\, Nurses\, Nuclear Medicine technologists and Radiographers. \n\n\n\n \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSofia VazSpeakerLisbon\, Portugal \n\n\n\n\n\nThiemo van NijnattenSpeakerMaastricht\, Netherlands \n\n\n\n\n\nPhilipp BackhausSpeakerMünster\, Germany \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/nuclear-medicine-in-breast-cancer-based-on-focus-meeting-6/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251201T100000
DTEND;TZID=Europe/Vienna:20251201T110000
DTSTAMP:20260419T094243
CREATED:20250513T093530Z
LAST-MODIFIED:20251118T083337Z
UID:2534-1764583200-1764586800@esmit.eanm.org
SUMMARY:Japanese vs. European View on Targeted Radionuclide Therapy
DESCRIPTION:This event is a collaboration between ESMIT and JSNM. The aim of the webinar is to compare the approach to targeted radionuclide therapy (TRT) in Japan and in Europe. The webinar will focus on the differences in the TRT environment in Japan vs. Europe\, including regulatory science and radiation protection regulation\, and more. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear Medicine Physicians \n\n\n\n \n\n\n\nFaculty\n\n\n\n\nTatsuya HigashiSpeaker \n\n\n\nWolfgang FendlerSpeaker \n\n\n\nConrad-Amadeus VoltinModerator \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/japanese-vs-european-view-on-targeted-radionuclide-therapy/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251120T090000
DTEND;TZID=Europe/Vienna:20251121T123000
DTSTAMP:20260419T094243
CREATED:20241017T084331Z
LAST-MODIFIED:20250929T122752Z
UID:1966-1763629200-1763728200@esmit.eanm.org
SUMMARY:Focus on FDG PET/CT in Inflammatory and Infectious Diseases
DESCRIPTION:Inflammation comes from the Latin word inflammare\, to ignite or to set on fire – we want to ignite your interest in imaging inflammation and infection. \n\n\n\nInflammatory and infectious diseases can be clinically challenging. Many are systemic with highly variable clinical presentations and sometimes vague and non-specific symptoms and findings. Association with implanted material like artificial heart valves\, joint or vascular prostheses may hamper imaging or give rise to non-specific findings. \n\n\n\nAlthough the imaging strategy may still be considered unclarified in some settings\, [18F]FDG-PET/CT is now established as a key modality in the diagnostic workup of several inflammatory and infectious diseases. The course aims to provide the participants with an overview of the evidence and practical use of [18F]FDG-PET/CT in suspected inflammation and infection and covers the most well-established indications.  \n\n\n\nLed by European experts\, the sessions mix short overview lectures with interactive sessions to allow participants to engage in discussions and exchange experiences on daily practices with each other and the faculty. \n\n\n\nRegister nowThe course is fully booked. Please contact us at esmit@eanm.org if you would like to be added to the waiting list! \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nTo provide general insights into the use of [18F]FDG PET/CT in suspected or manifest inflammation and infection\, e.g. patient preparation and protocols\n\n\n\nTo provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific inflammatory diseases\, e.g. vasculitis\, polymyalgia rheumatica\, other reumatologic diseases\, and  sarcoidosis\n\n\n\nTo provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific infectious diseases\, e.g. fever and inflammation of unknown origin\, blood stream infections\, osteomyelitis and spondylodiscitis\, cardiac and vascular infections\n\n\n\nTo provide some insights into novel developments with this domain\, e.g. FAPI\, bacteria-specific tracers\, and long axial field of view scanners\n\n\n\nTo facilitate an open discussion on pro and cons of [18F]FDG PET/CT in suspected or manifest inflammation and infections\n\n\n\n\n\n\nTarget Audience\n\n\n\nNuclear medicine specialists with basic experience in reading [18F]FDG-PET/CT in inflammatory and infectious diseases.  \n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSoren HessSpeakerOdense\, Denmark \n\n\n\n\n\nOlivier GheysensSpeakerBrussels\, Belgium \n\n\n\n\n\nAyah NawwarSpeakerBristol\, UK \n\n\n\n\n\nGiorgio TregliaSpeakerLugano\, Switzerland \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/focus-on-fdg-pet-ct-in-inflammatory-and-infectious-diseases/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251114T133000
DTEND;TZID=Europe/Vienna:20251114T143000
DTSTAMP:20260419T094243
CREATED:20241017T081732Z
LAST-MODIFIED:20251112T090155Z
UID:1942-1763127000-1763130600@esmit.eanm.org
SUMMARY:Paediatric Thyroid Cancer
DESCRIPTION:This webinar aims to underly the most relevant differences with the adults DCT regarding epidemiology\, genetics\, pathology\, immunoistopathology\, diagnostic tools and treatment\, especially for RAI theranostic procedure. Additionally\, the webinar will also go over the main GL recommendations\, as well as present and discuss two emblematic or tricky cases. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\n\nThe aim of this course is to sensitise the attendees about the correct way to recognise\, diagnose and treat DTC in children.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\n\nPhysicians\, residents with special interest on endocrinlogy and endo-oncology\, nuclear medicine specialists\, nurses and technicians of nuclear medicine units.\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nSuggested Readings\n\n\n\n \n\n\n\n \n\n\n\n\nFrancis GL\, Waguespack SG\, Bauer AJ\, Angelos P\, Benvenga S\, Cerutti JM\, Dinauer CA\, Hamilton J\, Hay ID\, Luster M\, Parisi MT\, Rachmiel M\, Thompson GB\, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. PMID: 25900731; PMCID: PMC4854274.\n\n\n\nLebbink CA\, Links TP\, Czarniecka A\, Dias RP\, Elisei R\, Izatt L\, Krude H\, Lorenz K\, Luster M\, Newbold K\, Piccardo A\, Sobrinho-Simões M\, Takano T\, Paul van Trotsenburg AS\, Verburg FA\, van Santen HM. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022 Nov 29;11(6):e220146. doi: 10.1530/ETJ-22-0146. PMID: 36228315; PMCID: PMC9716393.\n\n\n\nCzarniecka A\, Woźniak G\, Kropińska A\, Jarząb B\, Handkiewicz-Junak D. Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]. Endokrynol Pol. 2019;70(4):357-366. doi: 10.5603/EP.a2019.0033. PMID: 31489960.\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n\n\nDesiree DeandreisSpeaker \n\n\n\n\n\nCatia OliantiModerator \n\n\n\n\n\nLivia LamartinaSpeaker \n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/paediatric-thyroid-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251107T133000
DTEND;TZID=Europe/Vienna:20251107T143000
DTSTAMP:20260419T094243
CREATED:20241017T081503Z
LAST-MODIFIED:20251104T110112Z
UID:1940-1762522200-1762525800@esmit.eanm.org
SUMMARY:Nuclear Medicine-related Highlights from ESMO 2025
DESCRIPTION:This ESMO 2025 webinar will cover a range of topics\, including the latest advancements treatment options\, imaging modalities and performant tracers related to solid and liquid tumors. The focus of this Live event will be the recent advances in solid & liquid tumor treatment\, clinical trials and emerging therapies\, biomarkers in solid tumors and multidisciplinary approaches. The importance of collaboration among medical oncologists\, radiologists\, nuclear medicine physicians\, pathologists and surgeons will be underlined\, based on clinical examples. Challenges and opportunities in immunotherapy for solid tumors will also be addressed\, with special attention for personalized treatment plans in specific cancers\, like lung cancer\, breast cancer\, colorectal and prostate cancer. \n\n\n\nPlease note that the webinar will be recorded\, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform\, under the webinar title. A handout of the presentation materials will also be available on the platform. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nAttendees will get insight into recent advances in solid/ liquid tumor treatment\n\n\n\nAttendees will be familiarized with the latest developments when diagnosing\, staging and treating different types of solid and liquid tumors.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nFellows and Medical Specialists in Nuclear Medicine\, Radiology\, Medical Oncology\, Urology\, Surgery\, Pathology and Radiation Oncology\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nDavid KerstingModerator \n\n\n\n\n\nKarolien GoffinSpeaker \n\n\n\n\n\nMatthias EiberSpeaker \n\n\n\n\n\n\n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/nuclear-medicine-related-highlights-from-esmo-2025/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250919T133000
DTEND;TZID=Europe/Vienna:20250919T143000
DTSTAMP:20260419T094243
CREATED:20250225T110337Z
LAST-MODIFIED:20250911T085022Z
UID:2253-1758288600-1758292200@esmit.eanm.org
SUMMARY:Radiation Safety for Oncological Patients before and after Nuclear Medicine Procedures and Radiation Safety of Nursing Staff
DESCRIPTION:This webinar will emphasize the critical importance of radiation protection in safeguarding both the occupational health of care providers and the well-being of patients undergoing radionuclide therapy. \n\n\n\nIt will underscore the necessity of adhering to established guidelines and protocols when handling radioactive materials to ensure safety and treatment efficacy. \n\n\n\nFurthermore\, the session will explore the role of interprofessional collaboration and continuing education among health care providers in enhancing radiation safety practices. It will also present evidence-based strategies to mitigate patients’ symptoms associated with the adverse effects of radionuclide treatment. \n\n\n\n\n\n\n\n \n\n\n\nRegister now!Enrol in the live webinar now for free! Register now\n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo identify the primary steps for introducing newly hired health care staff to radionuclide therapy protocols and recognize the importance of continuous education in maintaining adherence to institutional safety and procedural standards.\n\n\n\nTo evaluate various educational methods and strategies used to train health care providers—including nurses\, caregivers\, seasonal workers\, and clinical assistants—in the principles\, procedures\, and safety protocols of radionuclide therapy.\n\n\n\nTo demonstrate effective patient education techniques and symptom management strategies for individuals undergoing radionuclide therapy\, with attention to minimizing adverse effects and enhancing patient comprehension.\n\n\n\nTo compare different radiation safety protocols and clinical guidelines associated with Lutathera and radioiodine therapies\, with respect to implications for both patients and health care providers.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\nAll health care providers involved in the care of oncological patients undergoing radionuclide treatment in clinical practice \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nLace MatarloSpeaker \n\n\n\n\n\nMatthias Hellberg-NaegeleModerator \n\n\n\n\n\nSigrid Leide SvegbornSpeaker
URL:https://esmit.eanm.org/event/radiation-safety-for-oncological-patients-before-and-after-nuclear-medicine-procedures-and-radiation-safety-of-nursing-staff/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250901T000000
DTEND;TZID=Europe/Vienna:20250901T235959
DTSTAMP:20260419T094243
CREATED:20251001T090654Z
LAST-MODIFIED:20251001T115837Z
UID:1349-1756684800-1756771199@esmit.eanm.org
SUMMARY:NucMed Essentials - MSK Basics
DESCRIPTION:UEMS EACCME has granted the accreditation of CME credits for this event. \n\n\n\n \n\n\n\n \n\n\n\nNuclear Medicine Essentials: The Basics of MSK provides a comprehensive introduction to musculoskeletal applications in nuclear medicine\, focusing on both diagnostic and therapeutic techniques. Participants will explore the fundamental principles of bone scintigraphy\, including its physiological basis\, imaging protocols\, and wide range of clinical applications\, with emphasis on its continued importance in patient care. The course also delves into advanced imaging through NaF PET\, highlighting its uptake mechanisms\, technical considerations\, and growing role in oncology and other clinical contexts. Building on these diagnostic foundations\, the course transitions into therapeutic strategies\, such as the use of Radium-223 in the treatment of bone metastases\, with attention to efficacy\, safety\, and radioprotection measures. \n\n\n\nBeyond theoretical understanding\, the program emphasizes practical application and clinical relevance. Learners will gain exposure to cutting-edge research\, evidence-based workflows\, and therapeutic innovations in the field. Radiosynovectomy for arthritis treatment is presented as an important example of nuclear medicine’s therapeutic scope\, with procedural insights and expected outcomes supported by real-world case demonstrations. Departmental video presentations supplement each topic\, offering participants a unique opportunity to see workflows and protocols in practice. By the end of the course\, attendees will not only understand the fundamentals of musculoskeletal nuclear medicine but also appreciate its evolving role in modern imaging and therapy.  \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nUnderstand the fundamentals of bone scan techniques:– Describe the theoretical considerations and acquisition protocols for bone scans.– Explain the clinical applications of bone scans across various pathologies.\n\n\n\nGain insights into NaF PET for bone imaging:– Summarize the theoretical considerations and acquisition protocols specific to NaF PET.– Recognize the essential applications of NaF PET in oncology and other clinical cases.\n\n\n\nExplore therapeutic approaches for bone metastases using bone-seeking agents:– Review current theoretical knowledge and recent publications on the treatment of bone metastases.– Identify practical considerations and procedural steps involved in bone-seeking agent therapies.\n\n\n\nLearn the application of radiosynovectomy in managing arthritis:– Describe the indications\, procedures\, and expected outcomes of radiosynovectomy for arthritis treatment.\n\n\n\nApply knowledge through visual and practical insights from real-world clinical settings:– Assess clinical workflows and procedural nuances via department video presentations for each session.\n\n\n\n\n\n\n\nNuclear Medicine Physicians and Residents\n\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the full event programme.  View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nKnut LiepeSpeaker \n\n\n\n\n\nJules Zhang-YinSpeaker \n\n\n\n\n\nPaolo TurcoSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration Fee\n\nCourse Fee               € 0.-  \n\n\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once registered\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/evidence-based-recommendations-on-18ffdg-pet-ct-imaging-in-fuo-in-children-and-adults/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Online Course,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250601T000000
DTEND;TZID=Europe/Vienna:20250601T235959
DTSTAMP:20260419T094243
CREATED:20251030T142906Z
LAST-MODIFIED:20251031T095911Z
UID:1346-1748736000-1748822399@esmit.eanm.org
SUMMARY:Bringing Alpha Therapies into Clinical Practice
DESCRIPTION:UEMS EACCME has granted the accreditation of 3 CME credits for this event. \n\n\n\n \n\n\n\n \n\n\n\nThis online course offers a comprehensive introduction to alpha therapy in nuclear medicine\, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences\, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting radioisotopes to deliver lethal doses of radiation directly to cancer cells while sparing healthy tissues. It is highly efficient and lately increasingly explored for scientific purposes in the oncologic domain . With this course we aim at bringing Alpha Therapies into clinical practice through various\, relevant presentations. A panel of experts and EANM members will update you on the type of alpha-emitting radioisotopes available\, describing all important steps required for production and radiopharmaceutical development. The advantages\, but also the challenges related to the use of Alpha therapy will amply be discussed and supported by clinical examples. You will be initiated in the existing and ongoing therapeutic trials\, with the best yet to come. Dosimetry will play a pivotal role in this course\, underlying its role in clinical practice. Finally\, The Alphamet project will be presented\, allowing you to get updated with the latest insights from Theranostics. \n\n\n\nRPH \n\n\n\nTargeted Alpha Therapy (TAT) represents a cutting-edge advancement in cancer treatment\, harnessing the potent\, cell-killing power of alpha particles to precisely destroy malignant cells while minimizing damage to surrounding healthy tissue. This part of the course course explores the transformative potential of TAT\, highlighting its exceptional potency\, unique ability to overcome radio-resistance\, and its role in modern theranostics. You’ll gain insight into the selection of optimal alpha-emitting radionuclides\, the biological advantages of short-range high-energy emissions\, and the complex challenges involved in the development\, production\, and clinical translation of these innovative therapies. Join us to deepen your knowledge and be part of the future of targeted radiopharmaceuticals in oncology. \n\n\n\nOncology \n\n\n\n \n\n\n\nIn this part of the course\, participants will explore the main advantages of alpha-emitting radionuclides in oncology\, while also gaining an understanding of the clinical challenges associated with their use. You will become familiar with the key clinical aspects of Alpha-Therapy\, supported by real-world perspectives and case insights. The course also highlights current and upcoming therapeutic trials\, providing valuable knowledge on the future direction of this rapidly evolving field. \n\n\n\nDosimetry \n\n\n\nParticipants will begin by exploring the basic concepts of dosimetry with alpha emitters\, highlighting key differences from beta emitter dosimetry. The course then delves into the clinical relevance of alpha dosimetry\, demonstrating how accurate dose assessments can inform and optimize the management of patients undergoing treatment with alpha radiotherapeutics. In addition\, the course presents the Alphamet project\, a major European initiative that addresses the specific metrological challenges associated with targeted alpha therapies. By examining the goals and contributions of Alphamet\, learners will gain insight into how this research supports the safe and effective integration of alpha therapy into routine clinical practice. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTo gain an overview of the main advantages of Alpha-radionuclides\n\n\n\nTo learn about the challenges of alpha emitters\, complex production; transport issues\, waste management and handling\n\n\n\nTo get insights on radiobiology: radiotoxicity & effectiveness\n\n\n\nTo have a comprehensive review of research candidates\n\n\n\nTo provide an overview of the main advantages when using Alpha-Therapy in clinical practice\n\n\n\nTo learn about the clinical challenges when using Alpha-Therapy\n\n\n\nTo get insights into current and future trials focusing on Alpha-Therapy\n\n\n\nTo learn the most basic aspects about dosimetry of alpha emitters showing the main differences with dosimetry of beta emitters\n\n\n\nTo learn how dosimetry results could be used in the management of patients treated with radiopharmaceuticals that include alpha emitters\n\n\n\nTo learn on the Alphamet project\, which addresses the unique and unmet metrological challenges of targeted alpha therapies\, contributing to their safe and optimised implementation into routine clinical practice\n\n\n\n\n\n\n\nNuclear medicine physicians\, radiologists\, medical oncologists\, urologists\, radiation oncologists\, medical physicists\, biologists\, researchers\n\n\n\nRadiochemists\, radiopharmacists\, physicists\, medical physicists\, biologists\n\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the full event programme.  View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nDana NiculaeSpeaker \n\n\n\nMarianna TosatoSpeaker \n\n\n\nPablo Mínguez GabiñaSpealer \n\n\n\nAna Denis-BacelarSpeaker \n\n\n\n\n\nEmma AnaheimSpeaker \n\n\n\nWolfgang FendlerSpeaker \n\n\n\nMike SathekgeSpeaker \n\n\n\nJoe O’SullivanSpeaker \n\n\n\n\n\nJanke KleynhansSpeaker \n\n\n\nMathias ZacherlSpeaker \n\n\n\nDaniela Oprea-LagerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once registered\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bringing-alpha-therapies-into-clinical-practice/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Online Course,Radiopharmaceuticals,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250601T000000
DTEND;TZID=Europe/Vienna:20250601T235959
DTSTAMP:20260419T094243
CREATED:20240215T124600Z
LAST-MODIFIED:20251016T123616Z
UID:1358-1748736000-1748822399@esmit.eanm.org
SUMMARY:Parathyroid Imaging (Self-paced)
DESCRIPTION:UEMS EACCME has granted the accreditation of 2.5 CME credits for this event. \n\n\n\nThis self-paced online course will offer a comprehensive exploration of the anatomy\, physiology\, and diagnostic tools related to parathyroid glands disorders. The course will cover a range of topics\, including the regulation of parathyroid hormone (PTH) secretion and his mechanisms of action\, etiology\, clinical manifestations\, and notably the diagnostic approaches ( laboratory and imaging)\, and treatment modalities especially concerning hyperparathyroidism. \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nAttendees will gain insights into structure and function of the parathyroid glands\, earning about etiology\, clinical manifestations\, diagnostic approaches focused on nuclear medicine and radiological techniques and treatment modalities of hyperparathyroidism. Through lectures\, and case studies\, participants will acquire the knowledge and skills necessary to diagnose and manage parathyroid disorders. \n\n\n\n\n\n\n\nTarget audience\n\n\n\n \n\n\n\nThis course is designed for Nuclear Medicine Physicians\, Endocrinologists and Radiologists. \n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\nLuca GiovanellaZurich\, Switzerland \n\n\n\nMurat TuncelAnkara\, Türkiye \n\n\n\nMichael KreisslMagdeburg\, Germany \n\n\n\nPetra PetranovicZagreb\, Croatia \n\n\n\n\nRegistration Details\n\n\n\nRegistration Fee\n\nCourse Fee              Free \n\n\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once enrolled\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/parathyroid-imaging/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250519T080000
DTEND;TZID=Europe/Vienna:20250520T120000
DTSTAMP:20260419T094243
CREATED:20250318T094512Z
LAST-MODIFIED:20250516T110910Z
UID:2372-1747641600-1747742400@esmit.eanm.org
SUMMARY:AD-LEARN Mini-course for Residents: How to Start Reading Brain Scans in Neurocognitive Disorders?
DESCRIPTION:The course aims to provide the participants with basic knowledge regarding nuclear and molecular medical imaging in the neurological field. In particular\, cerebral SPET and PET will be addressed. \n\n\n\n\n\n\n\nRegister now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna\, here is your chance to follow the course live online! Register now\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nClinical introduction and positioning where imaging is indicated: The aim is to understand the main indications of cerebral SPET and PET methods and the patient’s preparation before the examination.\n\n\n\nPrimer course: how to read a brain SPECT study: the aim is to understand how to acquire\, reconstruct\, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.\n\n\n\nPrimer course: how to read an FDG-PET brain study: the aim is to understand how to acquire\, reconstruct\, format and read an FDG  brain PET/CT. The main clinical patterns will also be presented.\n\n\n\nPeer-learning with tips and tricks\, and case presentation: the aim is to understand how to acquire\, reconstruct\, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear medicine specialists with little or no experience in reading SPET and PET neurological imaging. \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nIgor YakushevSpeakerMunich\, Germany \n\n\n\n\n\nStelvio SestiniSpeakerPrato\, Italy \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               Registration for this course is free\, but we will charge a €100 fee to book your seat\, which will be reimbursed upon attendance \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/esmit-ad-learn-mini-course-for-residents-how-to-start-reading-brain-scans-in-neurocognitive-disorders/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Instrumentation, Technology, Science,Onsite Course
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250515T090000
DTEND;TZID=Europe/Vienna:20250516T160000
DTSTAMP:20260419T094243
CREATED:20241017T083021Z
LAST-MODIFIED:20250311T115243Z
UID:1953-1747299600-1747411200@esmit.eanm.org
SUMMARY:CANCELLED: Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
DESCRIPTION:More information coming soon \n\n\n\nRegister nowThis course is cancelled. \n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\nMore information coming soon\n\n\n\n\n\n\n\nMore information coming soon\n\n\n\n\n\n\n\n\n\n\nProgrammeComing soon View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/focus-on-benign-thyroid-disease-from-thyroid-nodule-to-hyperthyroidism-and-immune-disease/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250501T000000
DTEND;TZID=Europe/Vienna:20250501T235959
DTSTAMP:20260419T094243
CREATED:20240215T120025Z
LAST-MODIFIED:20250422T093546Z
UID:1344-1746057600-1746143999@esmit.eanm.org
SUMMARY:Gynaecological Malignancies
DESCRIPTION:UEMS EACCME has granted the accreditation of 3 CME credits for this event. \n\n\n\nThe present course aims to describe the current status\, in terms of diagnosis and therapy for gynecological cancers. All the gynecological malignancies (i.e.\, ovary cancer\, endometrial cancer\, cervical and vaginal cancer) will be evaluated from the oncological and from diagnostic point of view\, with a major emphasis on the role of nuclear medicine\, both in diagnosis and therapy.  \n\n\n\nThe speakers are specialists in oncology\, radiology and nuclear medicine with a clinical experience in gynecological cancer and will provide some examples that can be found in every day clinical practice. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLearn about the current available therapies useful for the treatment of gynecological cancer; \n\n\n\nUnderstand the correct diagnostic flow-chart for the management of patients affected by gynecological cancer; \n\n\n\nDescribe the potential future perspectives in nuclear medicine to face gynecological cancer\, from a diagnostic and therapeutical point of view\n\n\n\n\n\n\n\nOncologists\, Radiologists\, Nuclear Medicine Physicians\, Technicians\, Endocrinologists\, Gynecologists\n\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the full event programme.  View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nCristina FerrariNuclear Medicine\, Italy \n\n\n\n\n\nGiulia TascaOncology\, Italy \n\n\n\n\n\nTeresa Margarida CunhaRadiology\, Portugal \n\n\n\n\n\n\n\nHelen Clare AddleyRadiology\, United Kingdom \n\n\n\n\n\nDesiree Deandreis Nuclear Medicine\, France \n\n\n\n\n\nOra Israel Nuclear Medicine\, Israel \n\n\n\n\n\n\n\nOzgul EckmekciogluNuclear Medicine\, Turkeye \n\n\n\n\n\nHenrique NabaisGynaecology\, Portugal \n\n\n\n\n\nMonica PiresGynaecology\, Portugal \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of Payment\n\nCourse Fee               € 300.- + Local VAT Rate \n\n\n\n\n\nCredit card via the ESMIT eLearning store \n\n\n\nCheques will not be accepted. \n\n\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once paid\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/gynaecological-malignancies/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250425T133000
DTEND;TZID=Europe/Vienna:20250425T143000
DTSTAMP:20260419T094243
CREATED:20241017T081307Z
LAST-MODIFIED:20250214T105155Z
UID:1936-1745587800-1745591400@esmit.eanm.org
SUMMARY:Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging (pre-recorded)
DESCRIPTION:more information coming soon \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/highlights-of-focus-meeting-6-shaping-the-future-of-breast-cancer-care-with-molecular-imaging-prerecorded/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250404T133000
DTEND;TZID=Europe/Vienna:20250404T143000
DTSTAMP:20260419T094243
CREATED:20241017T080415Z
LAST-MODIFIED:20250326T095143Z
UID:1928-1743773400-1743777000@esmit.eanm.org
SUMMARY:Radioiodine-Refractory Thyroid Cancer - Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?
DESCRIPTION:This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer\, highlighting recent clinical trials\, molecular targeting techniques\, and potential promising combination therapies. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo evaluate the current definition of radiorefractory thyroid cancer and identify its limitations in clinical practice\n\n\n\nTo learn new insights for radiorefractory thyroid cancer definition and their potential impact on treatment decisions\n\n\n\nTo learn current evidence-based redifferentiation strategies for restoring iodine avidity in radiorefractory thyroid cancer\n\n\n\nTo improve knowledge of redifferentiation mechanisms to develop personalized treatment plans for patients with radiorefractory thyroid cancer\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine physicians\, Endocrinologist\, Oncologist \n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nPetra PetranovicSpeaker \n\n\n\n\n\nMichael KreisslSpeaker \n\n\n\n\n\nLuca GiovanellaModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/radioiodine-refractory-thyroid-cancer-is-it-time-to-change-the-definition-in-the-light-of-novel-redifferentiation-therapies/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250320T090000
DTEND;TZID=Europe/Vienna:20250321T160000
DTSTAMP:20260419T094243
CREATED:20241017T082921Z
LAST-MODIFIED:20250314T130204Z
UID:1951-1742461200-1742572800@esmit.eanm.org
SUMMARY:Cardiac Amyloidosis Imaging: History\, Status Quo and Outlook
DESCRIPTION:This course provides a comprehensive overview of the multimodality diagnosis of cardiac amyloidosis. Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore\, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. Imaging modalities will include a focus on echocardiography\, cardiac MRI\, SPECT\, and PET\, with discussion of the various tracers available. It will be elaborated when which of the different imaging modalities can be used appropriately and multimodality concepts will also be discussed. The course content will be developed using numerous case examples. Furthermore\, the course participants should solve cases independently and discuss them with the other course participants. \n\n\n\n\n\n\n\nRegister nowRegistrations are closed. Please contact us at esmit@eanm.org if you are still interested in signing up for the course. \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nBecome familiar with the various imaging modalities available for the diagnosis of cardiac amyloidosis.\n\n\n\nTo learn the appropriate use of diagnostic options in cardiac amyloidosis (keyword: diagnostic algorithm).\n\n\n\nTo independently make the correct diagnosis of cardiac amyloidosis on the basis of case studies.\n\n\n\nTo learn the possibilities of quantification of SPECT and PET.\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nNuclear physicians\, cardiologists\, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics.\n\n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nStephan NekollaSpeakerMunich\, Germany \n\n\n\n\n\nRaffaella CalabrettaSpeakerVienna\, Austria \n\n\n\n\n\nCarmela NappiSpeakerNaples\,Italy \n\n\n\n\n\nDietrich BeitzkeSpeakerVienna\,Austria \n\n\n\n\nMichael PoledniczekSpeakerVienna\,Austria \n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/cardiac-amyloidosis-imaging-history-status-quo-and-outlook/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250221T133000
DTEND;TZID=Europe/Vienna:20250221T143000
DTSTAMP:20260419T094243
CREATED:20241017T075932Z
LAST-MODIFIED:20250217T121048Z
UID:1922-1740144600-1740148200@esmit.eanm.org
SUMMARY:Surgery in Neuroendocrine Neoplasms (NENs)
DESCRIPTION:Neuroendocrine tumours (NETs) are a rare but clinically significant group of malignancies arising from neuroendocrine cells\, often presenting in the gastrointestinal tract or lungs. While NETs account for a small fraction of overall cancer cases\, their incidence is steadily rising. Radioguided surgery has emerged as a highly effective approach for treating NETs\, particularly in cases of primary tumours or oligometastatic disease\, where nuclear medicine imaging precisely localizes the lesions and surgical resection is feasible. \n\n\n\nThis session will explore the current landscape of radioguided surgery\, with a specific focus onneuroendocrine tumour applications. We will begin by reviewing the latest tracers and instrumentation employed in radioguided procedures\, discussing their mechanisms\, advantages\, and limitations. Following this\, we will delve into the clinical integration of these tracers and devices\, examining their role in the routine surgical workflow for NETs. By highlighting the practical implications and clinical outcomes\, this session aims to provide attendees with actionable insights into advancing care for patients with neuroendocrine tumours. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nAttendees will be able to describe the latest advancements in radiotracers and surgical instrumentation for radioguided neuroendocrine tumour surgery\, including their mechanisms of action and clinical benefits. \n\n\n\nAttendees will be able to evaluate the indications for radioguided surgery in neuroendocrine tumours\, such as primary tumours and oligometastatic disease\, based on pre-operative nuclear medicine imaging. \n\n\n\nAttendees will be able to outline the steps required to integrate novel radiotracers and devices into the clinical workflow\, from surgical planning to intraoperative application\, with a focus on improving patient outcomes.\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nSurgical oncologists\, nuclear medical physicians\, medical physicists\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nThomas WendlerModerator \n\n\n\n\n\nPedro Fragoso Costa Speaker \n\n\n\n\n\nJohn Orozco CortesSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/surgery-in-neuroendocrine-neoplasms-nens/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250207T133000
DTEND;TZID=Europe/Vienna:20250207T143000
DTSTAMP:20260419T094243
CREATED:20241017T075631Z
LAST-MODIFIED:20250203T100308Z
UID:1920-1738935000-1738938600@esmit.eanm.org
SUMMARY:Bone Scan Beyond Oncological Disease
DESCRIPTION:The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings\, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights the diagnostic enhancement of early-phase imaging for inflammatory conditions\, pain assessment\, and soft-tissue evaluation. \n\n\n\nNew treatment options for cardiac amyloidosis are increasing interest in early diagnosis of the disease. DPD scan is an excellent and non-invasive diagnostic modality in this diagnosis\, but detailed local\, whole body and SPECT/CT including calculation of different ratios are necessary for an accurate diagnosis. The presentation showed the performance of the examination\, clinical and medical letter examples.  \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinSpeakerArlon\, Belgium \n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bone-scan-beyond-oncological-disease/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241212T090000
DTEND;TZID=Europe/Vienna:20241213T120000
DTSTAMP:20260419T094243
CREATED:20240213T182114Z
LAST-MODIFIED:20250116T094547Z
UID:1247-1733994000-1734091200@esmit.eanm.org
SUMMARY:Algorithms for Dementia Imaging
DESCRIPTION:UEMS EACCME has granted the accreditation of 7 CME credits for this event. \n\n\n\nThe course will offer a comprehensive overview of basic\, theoretical and practical evidence-based concepts needed for a deep and thoughtful understanding of the use of [¹⁸F]FDG (FDG) Brain PET\, amyloid (Amy) PET and DaT SPECT in Neurological Disorders. A brief introduction will be given on the position that each imaging technique holds in the recent European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. Then\, short theoretical sessions on visual reading and semiquantification of FDG PET\, Amy PET and DaT SPECT will be associated with longer hands-on sessions\, for a practice-oriented learning specifically addressed to dementing disorders and neurodegenerative parkinsonian syndromes. Different approaches for semiquantification and subsequent scan reporting will be proposed and discussed. Clinical cases will be the starting point to better define the usefulness\, utility and accurate reading of PET and SPECT in Alzheimer’s disease\, other neurodegenerative dementias and Parkinsonian Syndrome.n coming soon \n\n\n\n\n\n\n\nSave yourself a seatRegistration closed. For last minute registration\, please email us at esmit@eanm.org Register now!\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nTo familiarise with the neuroimaging tools available to objectively assess brain glucose metabolism\, amyloid deposition and dopaminergic system integrity\, and their position in recent European recommendations \n\n\n\nTo learn strengths and weaknesses of different approaches for semiquantification \n\n\n\nTo appropriately choose a semi-quantitative support for image interpretation in various conditions\n\n\n\nThe course will provide important information on the most recent developments for an improved clinical practice\, of utmost importance for nuclear medicine physicians.\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nGeneral nuclear medicine specialists\, radiologists who want to update their knowledge on reading\, semiquantification and reporting of FDG PET\, Amy PET and DaT SPECT in terms of clinical indications\, reading skills and pitfalls. The constantly evolving role of Brain PET in neurodegenerative disorders makes the track of interest also for neurologists who want to improve their knowledge of cutting-edge Neuroimaging tools.\n\n\n\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nValentina BertiSpeakerFlorence\, Italy \n\n\n\n\n\nIgor YakushevSpeakerMunich\, Germany \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/algorhythms-for-dementia-imaging/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241206T133000
DTEND;TZID=Europe/Vienna:20241206T143000
DTSTAMP:20260419T094243
CREATED:20240213T193126Z
LAST-MODIFIED:20241203T102334Z
UID:1300-1733491800-1733495400@esmit.eanm.org
SUMMARY:Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
DESCRIPTION:With the arrival of new therapeutic tracers\, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy\, medical treatment\, chemotherapy). \n\n\n\nLearning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities and limitations of alpha and beta therapy in metastatic bone pain treatment \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinModeratorArlon\, Belgium \n\n\n\n\n\n\n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\nTatiana LouroSpeakerLisbon\, Portugal \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/treatment-of-metastatic-bone-pain-using-bone-seeking-agents-msk/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241202T100000
DTEND;TZID=Europe/Vienna:20241202T110000
DTSTAMP:20260419T094243
CREATED:20240702T080051Z
LAST-MODIFIED:20241119T122958Z
UID:1737-1733133600-1733137200@esmit.eanm.org
SUMMARY:Japanese vs. European View on Amyloid Imaging and Therapy (in collaboration with JSNM)
DESCRIPTION:The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However\, due to differences in clinical processes and insurance systems in each country\, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe\, CSF diagnosis is often performed first and amyloid PET is performed in selected patients. In Japan\, only either CSF diagnosis or amyloid PET is covered by public insurance\, so there is a trend toward performing the more expensive PET first. The use of amyloid PET in the setting of anti-AB therapy monitoring\, and its exact positioning in the biomarkers  flow-chart is not yet clearly defined. This webinar will present recent findings on the usefulness of amyloid PET and the differences in actual use between Europe and Japan. \n\n\n\nLearning Objectives: tba \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDonatienne Van WeehaegheModerator \n\n\n\n\n\n\n\n\n\n\n\nProf. Dr. med. Dr. biol. hum. Matthias Brendel\, MHBASpeakerDepartment leadBoard certified Nuclear Medicine physician Research lead for neurodegenerative disorders LMU Klinikum   Department of Nuclear MedicineUniversity Hospital of Munich \n\n\n\n\n\nDr. Kenji IshiiSpeakerDirectorDiagnostic Neuroimaging ResearchTokyo Metropolitan Institute for Geriatrics and GerontologyTokyo\, Japan \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/japanese-vs-european-view-on-amyloid-imaging-and-therapy-in-collaboration-with-jsnm/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241114T080000
DTEND;TZID=Europe/Vienna:20241115T170000
DTSTAMP:20260419T094243
CREATED:20240213T181944Z
LAST-MODIFIED:20241031T131739Z
UID:1243-1731571200-1731690000@esmit.eanm.org
SUMMARY:Focus on Molecular-guided Surgery
DESCRIPTION:An application has been submitted to the UEMS EACCME for CME accreditation. \n\n\n\nThe course has a hybrid format with on-site lectures and hands-on practical and technic sessions\, It will cover the basic and some advanced and future aspects of Radioguided surgery with a focus on the technologist’s work and support the multidisciplinary team in charge of Radioguided procedures.   \n\n\n\n\n\n\n\nSave yourself a seatRegistration closed. For last-minute sign up please contact esmit@eanm.org \n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nThis course aims to spread information and practice to technologist\, nurses\, medical staff (nuclear medicine\, surgeons\, radiologist)  in order to provide an interactive setting to share ideas and refine current and future approaches in the field of Radioguided Surgery\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nTo Define the radioguided surgery principles\, applications\, methodology. \n\n\n\nOverview the current state of the art of the radioguided surgery. \n\n\n\nList the clinical indications of introducing radioguided surgery to the patients. \n\n\n\nExplain the paper of a multidisciplinary team in the context of radioguided surgery. \n\n\n\nProtocols and methodologies of conventional NM exams used in radioguided surgery \n\n\n\nConventional nuclear medicine in the context of radioguided surgery: best practice\, radiation protection and safety\, organisation and patient management. \n\n\n\nTo provide the potential benefits of new technologies like IA and future perspectives.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSergi Vidal-SicartSpeaker \n\n\n\n\n\nChiara Maria GranaSpeaker \n\n\n\n\n\nRenato Valdés OlmosSpeaker \n\n\n\n\n\nJohn OrozcoSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 863.64 \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/focus-on-molecular-guided-surgery/
LOCATION:Hospital Clínico de Barcelona\, Carrer de Villarroel\, 170\, L'Eixample\, Barcelona\, 08036\, Spain
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240920T133000
DTEND;TZID=Europe/Vienna:20240920T143000
DTSTAMP:20260419T094243
CREATED:20240213T192107Z
LAST-MODIFIED:20240731T083213Z
UID:1294-1726839000-1726842600@esmit.eanm.org
SUMMARY:Paediatric Nuclear Medicine in Nephro-Urology
DESCRIPTION:The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology\, with particular attention to the choice of the radiotracer\, the correct patient preparation\, and the acquisition protocol. Some typical cases will show the main points of image processing and results visualization. The clinical part will deal with hydronephrosis and hydroureteronephrosis\, spacing from typical pelvicureteral junction obstruction to obstructive megaureter\, and some complex malformations\, such as duplex kidneys. The selected cases will pinpoint the critical clues used in interpreting and reporting the scintigraphic studies and the integration of scintigraphic data with other imaging modalities (ultrasounds\, MRI\, etc.) in evaluating paediatric nephrourology patients. \n\n\n\nLearning Objectives: The aim of this course is to review the methodology and the main indications for scintigraphic studies in paediatric nephro-urology\, taking into accounts the more relevant and recent international guidelines and offering various examples taken from the current clinical practice. \n\n\n\nSuggested Readings:1. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children2. EANM procedural recommendations for managing the paediatric patient diagnostic nuclear medicine \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDiego CecchinModeratorPadua\, Italy \n\n\n\n\n\nPietro ZucchettaSpeakerPadua\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/paediatric-nuclear-medicine-in-nephro-urology/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240906T133000
DTEND;TZID=Europe/Vienna:20240906T143000
DTSTAMP:20260419T094243
CREATED:20240213T191555Z
LAST-MODIFIED:20240710T090914Z
UID:1291-1725629400-1725633000@esmit.eanm.org
SUMMARY:FDG-PET/CT in Breast Cancer
DESCRIPTION:Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality\, therefore being a major concern. 2-[18F]FDG PET/CT is commonly used in the clinical management of patients with breast cancer\, with significant impact on clinical management. Currently\, there is robust evidence supporting the usefulness of 2-[18F]FDG PET/CT in the initial staging of patients with locally advanced and metastatic breast cancer\, in the early assessment of treatment response and in the early detection of recurrence. The first presentation of this webinar will summarize the recently published “Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer” which was endorsed by other relevant societies in the subject of breast cancer (ACR\, ESSO\, ESTRO\, EUSOBI/ESR\, and EUSOMA). Updated information to support the recommendations to perform 2-[18F]FDG PET/CT in no special type breast cancer in different clinical settings will be provided. Despite no special type breast cancer presenting high 2-[18F]FDG avidity\, other breast cancer subtypes seem to be better evaluated with other PET radiopharmaceuticals. Therefore\, the second presentation will address the potential role of [18F]FES\, [89Zr]Trastuzumab\, [18F]Sodium fluoride (NaF)\, [18F]Fluciclovine (FACBC)\, [89Zr]Pembrolizumab and FAPI-ligands in breast cancer. During this webinar we want to brainstorm about the role of PET/CT in the different subtypes and clinical scenarios of patients with breast cancer. The webinar will be enriched by interactive clinical case discussion\, aiming to resemble the challenges found in daily clinical practice. \n\n\n\nLearning Objectives:  \n\n\n\n\nGeneral aspects to avoid false positive and false negative findings on 2-[18F]FDG PET/CT.\n\n\n\nDiagnostic accuracy of 2-[18F]FDG PET/CT compared to conventional imaging modalities.\n\n\n\nRecommendations for performing 2-[18F]FDG PET/CT in the initial staging\, in assessing response to therapy and in assessing recurrence.\n\n\n\nAppropriate PET radiopharmaceuticals to better address each breast cancer subtype.\n\n\n\nSpecific characteristics\, physiological biodistribution\, advantages and disadvantages of PET radiopharmaceuticals used in breast cancer beyond 2-[18F]FDG.\n\n\n\nGeneral interpretation criteria to optimize the information provided in the final PET/CT report.\n\n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nLioe-Fee de Geus-OeiModeratorLeiden\, Netherlands \n\n\n\n\n\nSofia VazSpeakerLisbon\, Portugal \n\n\n\n\n\nLidija AntunovicSpeakerMilan\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fdg-pet-ct-in-breast-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240705T133000
DTEND;TZID=Europe/Vienna:20240705T143000
DTSTAMP:20260419T094243
CREATED:20240213T191043Z
LAST-MODIFIED:20240701T122643Z
UID:1289-1720186200-1720189800@esmit.eanm.org
SUMMARY:Guidelines for the Use of FDG PET/CT in Infection and Inflammation 2.0
DESCRIPTION:General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection. \n\n\n\nLearning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in infection and inflammation\, based on the updated guidelines for nuclear medicine practice provided by the EANM/SNMMI. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nAndor GlaudemansModeratorGroningen\, Netherlands \n\n\n\n\n\n\n\n\n\n\n\nOlivier GheysensSpeakerBrussels\, Belgium \n\n\n\n\n\nGad AbikhzerSpeakerMontreal\, Canada \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/guidelines-for-the-use-of-fdg-pet-ct-in-infection-and-inflammation-2-0/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240627T090000
DTEND;TZID=Europe/Vienna:20240628T170000
DTSTAMP:20260419T094243
CREATED:20240213T181456Z
LAST-MODIFIED:20240627T125940Z
UID:1238-1719478800-1719594000@esmit.eanm.org
SUMMARY:Role of FDG-PET in Paediatric Hodgkin and Non-Hodgkin Lymphomas
DESCRIPTION:UEMS EACCME has granted the accreditation of 8 CME credits for this event. \n\n\n\nA large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology\, aetiological factors\, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: staging and therapeutic management\, the importance of the imaging-based assessment\, the role of Deauville classification\, prognostic aspects\, surveillance\, and the management of recurrent/treatment resistant forms in PHL and NHL. Current state of experimental tracers research. Future perspectives: novel radiotracers\, evaluation of rare entities and advanced image analysis.  \n\n\n\nMany case readings will be presented to the attendees to train them in interpreting and concluding 18FDG in the crucial assessment point into diagnostic- therapeutic PHL and NHL protocols. \n\n\n\nEach attendee is also asked to present a personal tricky case\, proposed to the experts and to the other attendees. This allows better communication among the attendees and a more interactive practical session. \n\n\n\n\n\n\n\nSave yourself a seatThe registration is closed. For last minute interest\, contact esmit@eanm.org  Register now!\n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nResidents\, NM specialist approaching paediatric ematology-oncology\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nThe aim of this course is initially to refresh and update clinical setting from the point of view of the pediatric Oncologist: epidemiology\, aetiological factors\, and general classification of Pediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies. \n\n\n\nThe two nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas and about the importance of imaging-based assessment\, and the role of Deauville classification in the main forms of PHL and NHL.  \n\n\n\nThe current state of experimental tracers research and future perspectives: novel radiotracers\, evaluation of rare entities and advanced image analysis. Two interactive sessions with a lot of case reading to train the attendees in the evaluation\, interpretation and comparison of 18FDG-PET-CT.  \n\n\n\n\n\n\n\n\n\nProgrammeClick to view the preliminary programme View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nMarta PillonSpeakerItaly \n\n\n\n\n\nPinar KiratliSpeakerTürkiye \n\n\n\n\n\nFrancesco FizSpeakerItaly \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee Breaks on each Course Day\n\n\n\nLunch on first Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/role-of-fdg-pet-in-paediatric-hodgkin-and-non-hodgkin-lymphomas/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240614T133000
DTEND;TZID=Europe/Vienna:20240614T143000
DTSTAMP:20260419T094243
CREATED:20240213T190705Z
LAST-MODIFIED:20240611T073044Z
UID:1285-1718371800-1718375400@esmit.eanm.org
SUMMARY:Cardiovascular PET-CT and PET-MR Imaging
DESCRIPTION:Patients workflows and acquisition protocols in PET/CT and PET/MR with different radiotracers for cardiovascular nuclear medicine imaging. \n\n\n\nLearning Objectives: To learn how to manage radioactive generators 82Sr/82Rb and to acquire cardiovascular imaging in PET/CT or PET/MR and other acquisition protocols. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nPaolo TurcoModeratorPadua\, Italy \n\n\n\n\n\nStephan NekollaModeratorMunich\, Germany \n\n\n\n\n\n\nSylvia SchachoffSpeakerMunich\, Germany \n\n\n\nIan ArmstrongSpeakerManchester\, UK \n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiovascular-pet-ct-and-pet-mr-imaging/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240425T090000
DTEND;TZID=Europe/Vienna:20240426T130000
DTSTAMP:20260419T094243
CREATED:20240213T173431Z
LAST-MODIFIED:20240422T130323Z
UID:1206-1714035600-1714136400@esmit.eanm.org
SUMMARY:Early Bone SPECT in Clinical Practice
DESCRIPTION:UEMS EACCME has granted the accreditation of 8.5 CME credits for this event. \n\n\n\nEarly phase SPECT has the potential to expand the diagnosis spectrum of disphosphonate scintigraphy in non-oncologic situations. Incorporated in a clinical routine\, it has the ability to focus the nuclear medicine physician attention on the most inflammatory lesions whichever they might be osseous\, para-osseous ou extra-osseous. Our 1.5 day course is intended to be a practical workshop for nuclear medicine physician interested in nuclear osteo-articular imaging\, whether they have an experience in early phase SPECT or not. It will cover the physiology of early phase physiology\, technical aspects\, interpretation guide\, most common type of lesions encountered\, with an emphasis on anatomy and CT semiology and an outlook on targeted treatment such as synoviorthesis. \n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\nHow and when to perform an early phase SPECT\n\n\n\nHow to integrate early phase\, late phase\, CT and clinical findings to elaborate a diagnosis\n\n\n\nHow to articulate our diagnosis with therapeutic tools such as synoviorthesis\, corticosteroid infiltrations and other methods\n\n\n\n\n\n\n\nNuclear medicine physician\, junior or senior\, with an interest in hybrid imaging and osteoarticular field. No experience in early phase SPECT needed.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nKnut LiepeSpeakerKlinikum Frankfurt (Oder)\, Germany \n\n\n\n\n\nDavid MorlandSpeakerUniversité de Reims Champagne-Ardenne\, France \n\n\n\n\n\nNicolas IcardSpeakerCentre Hospitalier de Saint Brieuc Yves Le Foll\, France \n\n\n\n\n\nJules ZhangSpeakerVivalia\, Hôpital d’Arlon\, Belgium \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee Breaks on each Course Day\n\n\n\nLunch on Day 1\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/early-bone-spect-in-clinical-practice/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240209T133000
DTEND;TZID=Europe/Vienna:20240209T143000
DTSTAMP:20260419T094243
CREATED:20240220T172054Z
LAST-MODIFIED:20240220T172055Z
UID:1465-1707485400-1707489000@esmit.eanm.org
SUMMARY:Cardiac Hybrid Imaging
DESCRIPTION:This webinar will provide knowledge about hybrid imaging SPECT/ CT and PET/CT: CT acquisition protocol\, added value of CACS and incidental findings on CTAC. \n\n\n\n \n\n\n\nLearning Objectives: The aim of the webinar is to: \n\n\n\n\nKnow about the indications for hybrid imaging in CAD \n\n\n\nDiscuss advantages and challenges \n\n\n\nGet to know the protocols \n\n\n\nKnow how to set up a hybrid imaging in your department\n\n\n\n\n\n\n\n\nWatch the recording in our Video LibraryEnter the eLearning store to register for the Annual Access Plan FOR FREE. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nFabien HyafilModeratorParis\, France \n\n\n\n\n\n\n\n\n\n\n\nFederico CaobelliSpeakerBern\, Switzerland \n\n\n\n\n\nRonny BuechelSpeakerZurich\, Switzerland \n\n\n\n\n\nAntti SarasteSpeakerTurku\, Finland \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiac-hybrid-imaging/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240202T133000
DTEND;TZID=Europe/Vienna:20240202T143000
DTSTAMP:20260419T094243
CREATED:20240220T171246Z
LAST-MODIFIED:20240220T171247Z
UID:1461-1706880600-1706884200@esmit.eanm.org
SUMMARY:Diagnostic and Therapy of Medullary Thyroid Cancer
DESCRIPTION:This webinar will provide the evidence for PET imaging in medullary thyroid cancer according to the literature and the to international recommendations with a focus on the available radiopharmaceuticals and perspectives. \n\n\n\nLearning Objectives: The aim of this webinar is to understand and to learn the correct use of PET radiopharmaceuticals for staging and restaging medullary thyroid cancer. \n\n\n\n\n\n\n\nWatch the recording in our Video LibraryEnter the eLearning store to register for the Annual Access Plan FOR FREE. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDesiree DeandreisModeratorGustave Roussy – Villejuif\, France \n\n\n\n\n\n\n\n\n\n\n\nLuca GiovanellaSpeakerUniversity of Zürich – Zurich\, Switzerland \n\n\n\n\n\nJulien HadouxSpeakerENDOCAN-TUTHYREF network – Villejuif\, France \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/diagnostic-and-therapy-of-medullary-thyroid-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
END:VCALENDAR